Tag: Hatch-Waxman
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
8 Aug 2025
Imodium: Fast Relief for Diarrhoea, Uses, Side Effects, and Tips
-
1 Feb 2026
Managing Multiple Medications: How to Reduce Drug Interactions and Stay Safe
-
14 Nov 2025
How to Report a Pharmacy Error and What Happens Next
-
16 Nov 2025
Cannabis and CNS Depressants: Risks of Combined Sedation and How to Stay Safe
-
2 Dec 2025
Severe Hypoglycemia and Hyperglycemia from Diabetes Medications: Emergency Care You Need to Know